MK-3475 effective against melanoma

Cancer Discov. 2014 Aug;4(8):863-4. doi: 10.1158/2159-8290.CD-NB2014-095. Epub 2014 Jun 26.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Disease-Free Survival
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / immunology*
  • Melanoma / pathology
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / immunology
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal, Humanized
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • pembrolizumab